GeoVax Labs

-$0.27 (-6.49%) Today
+$0.09 (+2.31%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GeoVax Labs and other ETFs, options, and stocks.

About GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever; Zika virus and malari; human immunodeficiency virus (HIV); as well as immunotherapies for solid tumor cancers.

CEO
David A. Dodd
Employees
9
Headquarters
Smyrna, Georgia
Founded
1988

GOVX Key Statistics

Market Cap
24.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
251.19K
High Today
$4.13
Low Today
$3.84
Open Price
$4.12
Volume
242.05K
52 Week High
$8.71
52 Week Low
$2.56

GOVX Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure